309 related articles for article (PubMed ID: 24934216)
1. Anti-inflammatory loaded poly-lactic glycolic acid nanoparticle formulations to enhance myocardial gene transfer: an in-vitro assessment of a drug/gene combination therapeutic approach for direct injection.
Fargnoli AS; Mu A; Katz MG; Williams RD; Margulies KB; Weiner DB; Yang S; Bridges CR
J Transl Med; 2014 Jun; 12():171. PubMed ID: 24934216
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, characterization, and evaluation of paclitaxel loaded in six-arm star-shaped poly(lactic-co-glycolic acid).
Chen Y; Yang Z; Liu C; Wang C; Zhao S; Yang J; Sun H; Zhang Z; Kong D; Song C
Int J Nanomedicine; 2013; 8():4315-26. PubMed ID: 24235829
[TBL] [Abstract][Full Text] [Related]
3. Using poly(lactic-co-glycolic acid) microspheres to encapsulate plasmid of bone morphogenetic protein 2/polyethylenimine nanoparticles to promote bone formation in vitro and in vivo.
Qiao C; Zhang K; Jin H; Miao L; Shi C; Liu X; Yuan A; Liu J; Li D; Zheng C; Zhang G; Li X; Yang B; Sun H
Int J Nanomedicine; 2013; 8():2985-95. PubMed ID: 23990717
[TBL] [Abstract][Full Text] [Related]
4. Levofloxacin loaded chitosan and poly-lactic-co-glycolic acid nano-particles against resistant bacteria: Synthesis, characterization and antibacterial activity.
Hayee R; Iqtedar M; Albekairi NA; Alshammari A; Makhdoom MA; Islam M; Ahmed N; Rasool MF; Li C; Saeed H
J Infect Public Health; 2024 May; 17(5):906-917. PubMed ID: 38569270
[TBL] [Abstract][Full Text] [Related]
5. Suppression of collagen-induced arthritis by single administration of poly(lactic-co-glycolic acid) nanoparticles entrapping type II collagen: a novel treatment strategy for induction of oral tolerance.
Kim WU; Lee WK; Ryoo JW; Kim SH; Kim J; Youn J; Min SY; Bae EY; Hwang SY; Park SH; Cho CS; Park JS; Kim HY
Arthritis Rheum; 2002 Apr; 46(4):1109-20. PubMed ID: 11953991
[TBL] [Abstract][Full Text] [Related]
6. Fluorescence and electron microscopy probes for cellular and tissue uptake of poly(D,L-lactide-co-glycolide) nanoparticles.
Panyam J; Sahoo SK; Prabha S; Bargar T; Labhasetwar V
Int J Pharm; 2003 Aug; 262(1-2):1-11. PubMed ID: 12927382
[TBL] [Abstract][Full Text] [Related]
7. Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles.
Niu X; Zou W; Liu C; Zhang N; Fu C
Drug Dev Ind Pharm; 2009 Nov; 35(11):1375-83. PubMed ID: 19832638
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticles made of fluorescence-labelled Poly(L-lactide-co-glycolide): preparation, stability, and biocompatibility.
Weiss B; Schaefer UF; Zapp J; Lamprecht A; Stallmach A; Lehr CM
J Nanosci Nanotechnol; 2006; 6(9-10):3048-56. PubMed ID: 17048517
[TBL] [Abstract][Full Text] [Related]
9. Practical preparation procedures for docetaxel-loaded nanoparticles using polylactic acid-co-glycolic acid.
Keum CG; Noh YW; Baek JS; Lim JH; Hwang CJ; Na YG; Shin SC; Cho CW
Int J Nanomedicine; 2011; 6():2225-34. PubMed ID: 22114486
[TBL] [Abstract][Full Text] [Related]
10. Oral delivery of topotecan in polymeric nanoparticles: Lymphatic distribution and pharmacokinetics.
Jeong SH; Jang JH; Lee YB
J Control Release; 2021 Jul; 335():86-102. PubMed ID: 34015399
[TBL] [Abstract][Full Text] [Related]
11. Scale up, optimization and stability analysis of Curcumin C3 complex-loaded nanoparticles for cancer therapy.
Ranjan AP; Mukerjee A; Helson L; Vishwanatha JK
J Nanobiotechnology; 2012 Aug; 10():38. PubMed ID: 22937885
[TBL] [Abstract][Full Text] [Related]
12. The comparison of different daidzein-PLGA nanoparticles in increasing its oral bioavailability.
Ma Y; Zhao X; Li J; Shen Q
Int J Nanomedicine; 2012; 7():559-70. PubMed ID: 22346351
[TBL] [Abstract][Full Text] [Related]
13. Cellular delivery of PEGylated PLGA nanoparticles.
Pamujula S; Hazari S; Bolden G; Graves RA; Chinta DD; Dash S; Kishore V; Mandal TK
J Pharm Pharmacol; 2012 Jan; 64(1):61-7. PubMed ID: 22150673
[TBL] [Abstract][Full Text] [Related]
14. In vitro degradation of poly (D, L-lactide-co-glycolide) nanoparticles loaded with linamarin.
Hussein AS; Abdullah N; Ahmadun FR
IET Nanobiotechnol; 2013 Jun; 7(2):33-41. PubMed ID: 24046903
[TBL] [Abstract][Full Text] [Related]
15. Cardioprotective activity of placental growth factor in a rat model of acute myocardial infarction: nanoparticle-based delivery versus direct myocardial injection.
Lu ZX; Mao LL; Lian F; He J; Zhang WT; Dai CY; Xue S; Lu WG; Zhu HS
BMC Cardiovasc Disord; 2014 Apr; 14():53. PubMed ID: 24742302
[TBL] [Abstract][Full Text] [Related]
16. Intracellular drug delivery by poly(lactic-co-glycolic acid) nanoparticles, revisited.
Xu P; Gullotti E; Tong L; Highley CB; Errabelli DR; Hasan T; Cheng JX; Kohane DS; Yeo Y
Mol Pharm; 2009; 6(1):190-201. PubMed ID: 19035785
[TBL] [Abstract][Full Text] [Related]
17. The development and mechanism studies of cationic chitosan-modified biodegradable PLGA nanoparticles for efficient siRNA drug delivery.
Yuan X; Shah BA; Kotadia NK; Li J; Gu H; Wu Z
Pharm Res; 2010 Jul; 27(7):1285-95. PubMed ID: 20309616
[TBL] [Abstract][Full Text] [Related]
18. Effects of poly(lactic-co-glycolic acid) on preparation and characteristics of plasmid DNA-loaded solid lipid nanoparticles.
Zhu L; Xie S; Dong Z; Wang X; Wang Y; Zhou W
IET Nanobiotechnol; 2011 Sep; 5(3):79-85. PubMed ID: 21913789
[TBL] [Abstract][Full Text] [Related]
19. Encapsulation of alpha-1 antitrypsin in PLGA nanoparticles: in vitro characterization as an effective aerosol formulation in pulmonary diseases.
Pirooznia N; Hasannia S; Lotfi AS; Ghanei M
J Nanobiotechnology; 2012 May; 10():20. PubMed ID: 22607686
[TBL] [Abstract][Full Text] [Related]
20. PLGA-Chitosan Encapsulated IL-10 Nanoparticles Modulate Chlamydia Inflammation in Mice.
Yilma AN; Sahu R; Subbarayan P; Villinger F; Coats MT; Singh SR; Dennis VA
Int J Nanomedicine; 2024; 19():1287-1301. PubMed ID: 38348174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]